All transplant centers participating in CIBMTR must submit a Pre-TED (2400) Form for each allogeneic (related or unrelated) hematopoietic cell transplant (HCT). The Pre-TED is a requirement of the SCTOD for all United States transplant centers when either the stem cell donation or the transplant occurs within the United States. For more information regarding the SCTOD, see SCTOD Requirements.
Although data regarding recipients receiving autologous HCTs are not required to be submitted as part of the C.W. Bill Young Transplant Program, CIBMTR is highly committed to collecting data on these recipients for research studies. Centers choosing to report autologous data to CIBMTR must report on all autologous transplants performed at their center. For more information regarding data reporting for autologous HCT, review HCT in the Data Management Guide.
The Pre-TED may be submitted to CIBMTR up to two weeks prior to the start of the recipient’s preparative regimen (see Pre-TED (2400) Form Submission below).
Figure 1. Disabled Edit Form Icon
Figure 2. Hovered Text, Consent Not Yet Reported
Subsequent HCTs
If a recipient receives a subsequent HCT (excluding autologous rescues and allogeneic boosts, see below) post-infusion, the form sequences will start over again with another Pre-TED (2400); this includes recipients assigned to the TED Forms and the Comprehensive Report Forms by the form selection algorithm.
For the majority of subsequent HCTs, the recipient will remain on the original follow-up form track assigned by the form selection algorithm. For more information regarding center type and the form selection algorithm, see the Data Management Guide. A recipient may need to change tracks if enrolled on a study that requires comprehensive forms.
However, if the recipient receives an autologous HCT as a result of a poor graft or graft failure or an allogeneic infusion using a prior donor for poor graft function / insufficient donor chimerism, the form sequence will not start over again. Generally, these types of infusion (autologous rescue and allogeneic boosts) are used to treat the recipient’s poor graft response, rather than to treat the recipient’s disease.
Contact the CIBMTR Customer Service Center if the subsequent Pre-TED (2400) does not come due automatically.
For recipients of multiple transplants, completing the Indication for CIBMTR Data Reporting (2814) for the subsequent HCT will make the Pre-TED (2400) come due.
Transplant centers can use the FormsNet3SM application to determine if a Pre-TED (2400) Form is due by either:
- Accessing the Forms Due Report, or
- Entering the recipient’s unique ID (CRID) in the Patient Forms Due field.
Links to Sections of Form:
Q1 – 29: Recipient Information
Q30 – 66: Donor Information
Q67 – 96: Hematopoietic Cellular Transplant (HCT) and Cellular Therapy
Q97 – 104: Clinical Status of Recipient Prior to the Preparative Regimen
Q105 – 142: Comorbidities
Q143 – 156: Pre-HCT Preparative Regimen
Q157 – 161: Additional Drugs Given in the Peri-Transplant Period
Q162 – 174: GVHD Prophylaxis
Q175 – 177: Post-Infusion Disease Therapy Planned as of Day 0
Q178: Prior Exposure: Potential Study Eligibility
Manual Updates:
Sections of the Forms Instruction Manual are frequently updated. The most recent updates to the manual can be found below. For additional information, select the manual section and review the updated text.
If you need to reference the historical Manual Change History for this form, please reference the retired manual section on the Retired Forms Manuals webpage.
| Date | Manual Section | Add/Remove/Modify | Description |
|---|---|---|---|
| 4/24/2026 | 2400: Pre-TED | Add | Updated the non-myeloablative fludarabine + TBI regimen in table 1: Fludarabine + TBI < 200 cGY (single) |
| 4/24/2026 | 2400: Pre-TED | Modify | Clarified how to report the recipient’s highest degree or level of school: Select the option that best describes the recipient’s highest degree obtained / highest level of school completed at the start of the preparative regimen (or infusion if no preparative regimen was given). When reporting the highest degree obtained, select the degree or credential that has been completed at the time of the preparative regimen. When reporting the highest level of school completed, report the most advanced grade the recipient finished at the time of the preparative regimen using the following guidelines: – Under school age or no schooling: Recipient has not completed the 1st grade (including recipients who never attended school or who started 1st grade but did not complete it). – Up to 8th grade: Recipient completed at least 1st grade and up to and including 8th grade, but did not complete any grade beyond 8th. – 9th to 12th grade, no diploma: Recipient completed at least one grade between 9th and 12th but has not obtained a high school diploma or equivalent. |
| 1/23/2026 | 2400: Pre-TED | Add | Clarified Q12 intent: The intent of this question is to determine care access, regardless of the language spoken. Indicate if the recipient (or their parent, guardian, or legally authorized representative) requires interpreter services for any aspect of care, including verbal communication, reading, or other forms of assistance. Interpreters may include professional interpreters, family members, friends, or other individual who help facilitate communication. |
| 1/23/2026 | 2400: Pre-TED | Add | Dosing Weight Disabled blue note box added to Q143: Dosing Weight Disabled: With the Winter 2026 release (January 23, 2026), the Dosing weight used for preparative regimen orders question is disabled.. |
| 10/24/2025 | 2400: Pre-TED | Modify | Version 10 of the 2400: Pre-TED section of the Forms Instructions Manual released. Version 10 corresponds to revision 11 of the Form 2400. |
Need more help with this?
Don’t hesitate to contact us here.